Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Reexamination Certificate
2011-04-05
2011-04-05
Burkhart, Michael (Department: 1633)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
C435S320100, C536S023400
Reexamination Certificate
active
07919583
ABSTRACT:
Some aspects of the application describe materials and methods for making a molecular tether. A molecular tether, in certain embodiments, includes a target-DNA-binding domain having a specific binding affinity for a target-DNA segment in a host chromosome, a carrier-binding domain that specifically binds to a DNA segment on a carrier, and a spacer covalently bonded to the target DNA-binding domain and the carrier-binding domain.
REFERENCES:
patent: 5110802 (1992-05-01), Cantin et al.
patent: 5144019 (1992-09-01), Rossi et al.
patent: 5149796 (1992-09-01), Rossi et al.
patent: 5272262 (1993-12-01), Rossi et al.
patent: 5626877 (1997-05-01), Amsden et al.
patent: 5750380 (1998-05-01), Itakura et al.
patent: 5891108 (1999-04-01), Leone et al.
patent: 5972027 (1999-10-01), Johnson
patent: 5985575 (1999-11-01), Wickens et al.
patent: 5985661 (1999-11-01), Rossi
patent: 6013516 (2000-01-01), Verma et al.
patent: 6041252 (2000-03-01), Walker et al.
patent: 6057104 (2000-05-01), Hasty
patent: 6071305 (2000-06-01), Brown et al.
patent: 6074673 (2000-06-01), Guillen
patent: 6083996 (2000-07-01), Büyüktimkin et al.
patent: 6086582 (2000-07-01), Altman et al.
patent: 6086912 (2000-07-01), Gilman
patent: 6110498 (2000-08-01), Rudnic et al.
patent: 6126919 (2000-10-01), Stefely et al.
patent: 6132765 (2000-10-01), DiCosmo et al.
patent: 6136295 (2000-10-01), Edwards et al.
patent: 6142939 (2000-11-01), Eppstein et al.
patent: 6235312 (2001-05-01), Hobbs et al.
patent: 6235313 (2001-05-01), Mathiowitz et al.
patent: 6245349 (2001-06-01), Yiv et al.
patent: 6251079 (2001-06-01), Gambale et al.
patent: 6283947 (2001-09-01), Mirzaee
patent: 6283949 (2001-09-01), Roorda
patent: 6287792 (2001-09-01), Pardridge et al.
patent: 6296621 (2001-10-01), Masuda et al.
patent: 6296832 (2001-10-01), Ruoslahti et al.
patent: 6309370 (2001-10-01), Haim et al.
patent: 6309375 (2001-10-01), Glines et al.
patent: 6309380 (2001-10-01), Larson et al.
patent: 6309410 (2001-10-01), Kuzma et al.
patent: 6317629 (2001-11-01), Haak et al.
patent: 6346272 (2002-02-01), Viegas et al.
patent: 6350780 (2002-02-01), Garst et al.
patent: 6379382 (2002-04-01), Yang
patent: 6387124 (2002-05-01), Buscemi et al.
patent: 6387397 (2002-05-01), Chen et al.
patent: 6410017 (2002-06-01), Weisgerber et al.
patent: 6479626 (2002-11-01), Kim et al.
patent: 6489458 (2002-12-01), Hackett et al.
patent: 6555692 (2003-04-01), Dervan
patent: 6562570 (2003-05-01), Rossi et al.
patent: 6576759 (2003-06-01), Zeng et al.
patent: 6720478 (2004-04-01), Mahajan et al.
patent: 6794136 (2004-09-01), Eisenberg et al.
patent: 6809183 (2004-10-01), Mahajan
patent: 6903185 (2005-06-01), Kim et al.
patent: 2003/0036056 (2003-02-01), Rossi et al.
patent: 2003/0119017 (2003-06-01), McSwiggen
patent: 2003/0124513 (2003-07-01), McSwiggen
patent: 2003/0125281 (2003-07-01), Lewis et al.
patent: 2003/0130186 (2003-07-01), Vargeese et al.
patent: 2003/0139363 (2003-07-01), Kay et al.
patent: 2003/0144239 (2003-07-01), Agami et al.
patent: 2003/0148519 (2003-08-01), Engelke et al.
patent: 2003/0153519 (2003-08-01), Kay et al.
patent: 2003/0157691 (2003-08-01), Qin et al.
patent: 2003/0166282 (2003-09-01), Brown et al.
patent: 2003/0166512 (2003-09-01), Xie
patent: 2003/0217376 (2003-11-01), Ebens et al.
patent: 2004/0077572 (2004-04-01), Hackett et al.
patent: 2004/0203158 (2004-10-01), Hackett et al.
patent: 2004/0224336 (2004-11-01), Wagner
patent: 2005/0037385 (2005-02-01), Choo et al.
patent: 2005/0112620 (2005-05-01), Chan
patent: WO 92/06988 (1992-04-01), None
patent: WO 95/19788 (1995-07-01), None
patent: WO 99/25817 (1999-05-01), None
patent: WO 99/46372 (1999-09-01), None
patent: WO 00/60115 (2000-10-01), None
patent: WO 00/68399 (2000-11-01), None
patent: WO 01/30965 (2001-05-01), None
patent: WO 02/44321 (2002-06-01), None
patent: WO 02/097114 (2002-12-01), None
patent: WO 03/008573 (2003-01-01), None
patent: WO 03/020931 (2003-03-01), None
patent: WO 03/056022 (2003-07-01), None
patent: WO 03/066650 (2003-08-01), None
patent: WO 03/068797 (2003-08-01), None
patent: WO 03/070193 (2003-08-01), None
patent: WO 03/070750 (2003-08-01), None
patent: WO 03/070895 (2003-08-01), None
patent: WO 03/070914 (2003-08-01), None
patent: WO 03/070918 (2003-08-01), None
patent: WO 2004/009792 (2004-01-01), None
patent: WO 2004/065581 (2004-08-01), None
Biet et al (Stimulation of RecA-Mediated D-loop Formation by Oligonucleotide-Directed Triple-Helix Formation: Guided Homologous Recombination (GOREC). Biochemistry, 2001. 40:1779-1786.
Cui et al (RecA-Mediated, Targeted Mutagenesis in Zebrafish. Marine Biotechnology,2003. 5:174-184).
Anderson, (1998). Human gene therapy. Nature 392 (suppl): 25-30.
Ausubel, et al. (1994).Current Protocols in Molecular Biology, Contents V. 1, 2, and 3. Table of Contents.
Borelli et al. (1988). Targeting of an inducible toxic phenotype in animal cells. Proceedings of the National Academy of Sciences USA 85: 7572-7576.
Dove (2000). Milking the genome for profit. Nature Biotech. 18: 1045-1048.
Dupuy et al. (2001). Transposition and gene disruption using a mutagenic transposon vector in the male germline of the mouse. Genesis 30: 82-88.
Dupuy et al. (2002). Mammalian germ-line transgenesis by transposition. Proceedings of the National Academy of Sciences USA 99: 4495-4499.
Fischer et al. (2001). Regulated transposition of a fish transposon in the mouse germ line. Proceedings of the National Academy of Sciences USA 98: 6759-6764.
Hackett et al. (1999). Development of genetic tools for transgenic animals.INTransgenic Animals in Agriculture. CAB International, Wallingford, UK. 19-35.
Hackett et al. (2000). The molecular genetics of transgenic fish. Recent Advances in Marine Biotechnology 4: 77-145.
Horie et al. (2001). Efficient chromosomal transposition of a Tc1/mariner- like transposon Sleeping Beauty in mice. Proceedings of the National Academy of Sciences USA 98: 9191-9196.
Horie et al. (2003). Characterization ofSleeping Beautytransposition and its application to genetic screening in mice. Molecular and Cellular Biology 23: 9189-9207.
Ivics et al. (1997) Molecular reconstruction ofSleeping Beauty, a Tc1- like transposon from fish, and its transposition in human cells. Cell 91: 501-510.
Jaenisch (1988). Transgenic animals. Science 240: 1468-1474.
Marshall (2002). Clinical research. Gene therapy a suspect in leukemia-like disease. Science. 298: 34-35.
Miskey et al. (2003). The Frog Prince: a reconstructed transposon from Rana pipiens with high transpositional activity in vertebrate cells. Nucleic Acids Research 31: 6873-6881.
Montini et al. (2002). In vivo correction of murine tyrosinemia type I by DNA-mediated transposition. Molecular Therapy 6: 759-769.
Muir et al. (2002). Assessment of possible ecological risks and hazards of transgenic fish with implications for other sexually reproducing organisms. Transgenic Research 11: 101-114.
Niiler (2000). FDA, researchers consider first transgenic fish. Nature Biotechnology 18: 143.
Reichardt (2000). Will souped up salmon sink or swim? Nature 406: 10-12.
Verma et al. (1997). Gene therapy—promises, problems and prospects. Nature 389: 239-242.
Verma (2002). Success and setback: another adverse event. Molecular Therapy 6: 565-566.
Vigahl et al. (2002). Common physical properties of DNA affecting target site selection ofSleeping Beautyand other Tc1/marinertransposable elements. Journal of Molecular Biology 323: 441-452.
Yant et al. (2000). Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system. Nature Genetics 25: 35-41.
Yin et al. (2002). RNA-mediated gene regulation system: now and the future. International Journal of Molecular Medicine 10: 355-365.
Essner Jeffrey
Hackett Perry B.
Burkhart Michael
Dardi & Herbert, PLLC
Discovery Genomics, Inc.
LandOfFree
Integration-site directed vector systems does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Integration-site directed vector systems, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Integration-site directed vector systems will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2621143